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The pleiotropic cytokine interleukin-1b (IL-1b) can promote physiological cell migration, as well as
cancer cell invasion and metastasis. Its role in human trophoblast invasion, however, has not been
satisfactorily answered since direct, indirect as well as no effects on trophoblast motility have been
published. Therefore, the role of IL-1b has been re-evaluated by exclusively using human primary
trophoblast model systems. Immunoﬂuorescence of ﬁrst trimester placentae indicated IL-1 receptor 1
(IL-1R1) protein expression in ﬁrst trimester villous cytotrophoblasts (vCTB) and extravillous tropho-
blasts (EVT). The latter expressed higher mRNA levels of the receptor as shown by comparative gene chip
data of vCTB and EVT. Similarly, Western blot analyses and immunoﬂuorescence revealed a time- and
differentiation-dependent increase of IL-1R1 in primary EVT seeded on ﬁbronectin. IL-1b dose-
dependently elevated migration of isolated ﬁrst trimester EVT through ﬁbronectin-coated transwells,
which was inhibited in the presence of IL-1R antagonist (IL-1Ra), whereas proliferation of these cells was
not affected. Similarly, the interleukin did not alter proliferation of vCTB and cell column trophoblasts in
ﬂoating villi of early pregnancy, but promoted migration in villous explant cultures seeded on collagen I.
Western blot analyses of supernatants of primary EVT and ﬁrst trimester villous explant cultures revealed
IL-1b induced secretion of urokinase plasminogen activator (uPA), plasminogen activator inhibitor (PAI)-
1 and PAI-2, which was diminished upon combined IL-1b/IL-1Ra treatment. In conclusion, these data
suggest that IL-1b directly promotes trophoblast motility of ﬁrst trimester EVT involving the uPA/PAI
system.
 2012 Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Invasion of human extravillous trophoblasts (EVT) intomaternal
uterine tissues is essential for a successful pregnancy. Differenti-
ated EVT originate from placental anchoring villi attaching to the
uterine epithelial surface and develop into two distinct cell pop-
ulations, the interstitial cytotrophoblasts (iCTB) and the endovas-
cular cytotrophoblasts (eCTB). Whereas iCTB invade the uterine
decidua andmigrate towards the spiral arteries, eCTB directly enter
these vessels and adopt a vascular adhesion phenotype [1].
Remodelling of the spiral arteries, which is thought to be initiated
by uterine NK (uNK) cells, is a critical step in human placentation
requiring the coordinated actions of iCTB and eCTB for completion
of the process [2]. Transformation of the uterine vessels involves
replacement of maternal endothelial cells as well as trophoblast-
mediated apoptosis of vascular smooth muscle cells provokingx: þ43 1 40400 7842.
t (M. Knöﬂer).
-NC-ND license.disruption of the vascular wall [3]. Conversion of the vessels into
dilated conduits is thought to reduce contractility, pressure and
rate of blood ﬂow into the intervillous space supporting a constant
delivery of oxygen and nutrients to the developing fetus [4]. Fail-
ures in this vascular transformation process are associated with the
development of gestational diseases such as severe forms of
intrauterine growth restriction and preeclampsia [5]. Fluctuations
in oxygen concentrations may result in hypoxia and reoxygenation
of the placental villi provoking stress-mediated secretion of cyto-
kines and microparticles into the maternal circulation ﬁnally
causing the clinical symptoms of preeclampsia [6,7]. However,
abnormal trophoblast invasion might also play a role in early
pregnancy complications for example miscarriages [4].
Whereas molecular mechanisms controlling formation of
anchoring villi, cell columnproliferation and EVT differentiation are
largely unknown, numerous growth factors, chemokines and
cytokines expressed at the fetalematernal interface were shown to
increase EVT invasion [8e10]. These factors act through prominent
signalling cascades, such as PI3K/AKT, Raf/MEK/ERK, Rho/ROCK or
Wnt/b-catenin signalling [11]. However, trophoblast invasion is
a ﬁnely tuned process which is negatively affected by a variety of
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forming growth factor beta (TGFb), endostatin or interleukin-10 (IL-
10), secreted from decidual stromal cells, uNK cells or macrophages
[9]. To downregulate the invasive capacity of EVT, trophoblast-
derived proteases such as matrix metalloproteinases (MMP) and
urokinase plasminogen activator (uPA) are thought to be inhibited
by tissue inhibitors of metalloproteinases (TIMP) and plasminogen
activator inhibitors (PAI) secreted fromuterine cell types [8]. Hence,
despite its similarity to cancer cell invasion, trophoblast invasion is
precisely controlled in a time- and distance-dependent manner.
Another factor, interleukin-1 beta (IL-1b), qualiﬁes as a regulator
of EVT function since it is released from different uterine cells,
blastocysts and cultured trophoblasts [9,12,13]. Indeed, IL-1b
secreted from blastocysts was suggested to promote decidualisa-
tion and implantation [14] in agreement with the assumption that
the latter has characteristics of an inﬂammatory response.
However, IL-1b may have beneﬁcial as well as adverse effects on
reproductive cells likely depending on its local concentration and
the particular cell type. Aberrant IL-1b levels were shown to be
associated with a variety of gestational diseases such as
preeclampsia, preterm labour or spontaneous abortion [15]. The
adverse effects of the cytokine might be due to abnormal matrix
degradation and IL-1b-dependent recruitment of dendritic cells
and macrophages into the decidua [16]. With respect to primary
trophoblast cell invasion direct effects of IL-1b on MMP expression
and invasion have been observed [17], whereas others postulated
an indirect role of the cytokine in trophoblast motility by stimu-
lating secretion of chemotactic IL-8 from endometrial epithelial
cells [18]. Interestingly, invasion of the trophoblastic cell line
SGHPL-4 representing EVT was not affected in the presence of IL-1b
[19]. Therefore, IL-1 receptor 1 (IL-1R1) expression, IL-1b-depen-
dent proliferation and migration as well as protease secretion were
re-evaluated by exclusively using different primary trophoblast
model systems, i.e. primary EVT as well as ﬂoating and matrix-
attached ﬁrst trimester villous explant cultures.
2. Materials and methods
2.1. Tissue collection
Placental tissues of early pregnancy (between the 6th and 12th week of gesta-
tion, n ¼ 93) were obtained from legal abortions of uncomplicated pregnancies.
Utilisation of tissues was approved by the ethics committee of the Medical
University of Vienna requiring informed consent.
2.2. Preparation and cultivation of primary EVT
Primary EVT were isolated from ﬁrst trimester placentae between the 6th and
12th week of gestation according to a modiﬁed protocol of Tarrade et al. [20] by
additionally using Percoll density gradient centrifugation (10%e70%; Pharmacia,
Uppsala, Sweden). Brieﬂy, placentaewerewashed in ice-cold PBS and kept overnight
in DMEM/Ham’s F-12 medium (Invitrogen, Carlsbad, CA), supplemented with
0.05 mg/ml gentamicin (Invitrogen) and 2.5 mg/ml fungizone (Invitrogen). Villous
tips were scraped with a scalpel blade and digested two times in 0.125% trypsin
(Invitrogen) and 12.5 mg/ml DNase I (SigmaeAldrich, St.Louis, Missouri) in 10%
HBSSeMg/Ca-free medium (SigmaeAldrich) for 30 min at 37 C without agitation.
Subsequently, cells were pooled, ﬁltered through a 70 mm cell strainer (Greiner Bio-
One GmbH, Frickenhausen, Germany) and the cell suspension was separated by
Percoll density gradient centrifugation (1175 g, 24 min, 4 C). Isolated cells (between
35% and 50% Percoll layer) were cultivated on ﬁbronectin-coated (20 mg/ml, BD
Biosciences, Bedford, MA) wells in DMEM/Ham’s F-12 medium, supplemented with
10% FCS and 0.05 mg/ml gentamicin as mentioned [21]. For characterisation 1 105
cells were seeded on ﬁbronectin-coated Lab-Tek chamber slides (NalgeNunc Inter-
national, Penﬁeld, New York) and analysed by ﬂuorescence microscopy using
primary antibodies against cytokeratin-7 (CTK-7, monoclonal mouse, clone OV-TL
12/30, 8.3 mg/ml; Dako, Glostrup, Denmark) and vimentin (polyclonal rabbit,
20 mg/ml, GeneTex Inc., Irvine, CA). Alexa Fluor 488 (anti-mouse) and Alexa Fluor
568 (anti-rabbit) were used as secondary antibodies (2 mg/ml, Molecular Probes,
Invitrogen). Isolated cells were mostly CTK-7-positive (97%), largely vimentin-
negative, and expressed markers of EVT such as integrin a1 and integrin a5b1 in
a differentiation-dependent manner as mentioned [21].2.3. Immunoﬂuorescence of ﬁrst trimester placentae and primary EVT
First trimester placental (n ¼ 4) and decidua basalis tissues (n ¼ 3) were
embedded in parafﬁn and sectioned on a microtome, as described [22]. Brieﬂy, after
ﬁxation in 4% paraformaldehyde for 24 h at 4 C, tissue samples were dehydrated
and embedded in parafﬁn (Merck, New Jersey). Serial sections were prepared (3 mm),
deparafﬁnised and heated in a microwave (2  5 min, 850 W). Blocking procedures,
antibody stainings and immunoﬂuorescence were performed as mentioned [23].
The sections were incubated with primary antibodies against IL-1R1 (monoclonal
mouse, clone 40101, 10 mg/ml, LifeSpan Biosciences) and pan-keratin (KRT, cyto-
keratinwide-spectrum antibody, polyclonal rabbit, 1:100, GeneTex Inc.), followed by
secondary Alexa Fluor 488 anti-mouse and Alexa Fluor 568 anti-rabbit antibodies.
Irrelevant, isotype- and concentration-matched antibodies were used as controls.
Nuclei were visualised by 40 ,6-diamidino-2-phenylindole (DAPI, 1 mg/ml, Roche,
Mannhein, Germany). The stained sections were embedded in Fluoromount-G
(SouthernBiotech, Birmingham, AL) and pictures were taken at a 200 fold magniﬁ-
cation on a ﬂuorescence microscope (Olympus BX50, Hamburg, Germany). 1  105
primary EVT (n ¼ 3) were cultured on ﬁbronectin-coated chamber slides for 24 or
48 h and stained with primary antibodies against IL-1R1 and integrin a1 (ITGA1,
monoclonal mouse, clone FB12, 2 mg/ml; Chemicon, Millipore). Secondary anti-
bodies and isotypes controls were used as described above.
2.4. Migration of primary EVT
Migration of primary EVT (n ¼ 3, duplicates) was performed by using
ﬁbronectin-coated 12 mm pore transwell inserts (Millicell, Millipore, Billerica, MA)
as recently mentioned [21]. Brieﬂy, ﬁbronectin (0.5 mg/ml) was added to the upper
side of the inserts, which were incubated for 30 min at 37 C and subsequently
placed into 24-well plates containing 300 ml DMEM/Ham’s F-12 medium with 10%
FCS and 0.05 mg/ml gentamicin. 150,000 primary EVT, resuspended in DMEM/
Ham’s F-12 medium with 0.1% FCS, were incubated with human recombinant IL-1b
(1 ng/ml or 10 ng/ml, R&D Systems Inc., Minneapolis, MN) and/or human
recombinant IL-1Ra (40 ng/ml, R&D Systems Inc.) and added to the ﬁbronectin-
coated inserts. After 48 h of incubation, cells were washed in PBS, ﬁxed in ice-
cold methanol for 10 min and again washed in PBS. Subsequently, non-invaded
cells on the upper side of each insert were removed by a cotton swab and
membranes were cut out with a scalpel blade. Cells were stained with primary
anti-CTK-7 and secondary Alexa Fluor 488 anti-mouse antibodies together with
DAPI. Finally, membranes were placed on glass slides and embedded in
Fluoromount-G. Five non-overlapping pictures of each membrane representing
approximately 40e50% of the overall surface were taken (40 fold magniﬁcation),
cells were digitally counted by using the imaging software CellP (Olympus,
Hamburg, Germany). Motility was evaluated as the percentage of CTK-7-positive
cells compared to untreated control.
2.5. Migration in ﬁrst trimester villous explant cultures
Pieces of villous tissue of ﬁve different ﬁrst trimester placentae between the 7th
and 12th week of gestation were dissected under the microscope and cultivated on
collagen I (BD Biosciences)-coated dishes, allowing for trophoblast outgrowth and
migration as described elsewhere [21,22]. After adherence to the matrix (4e7 h),
villous explants were covered with DMEM/Ham’s F-12 medium, supplemented
with 0.05 mg/ml gentamicin and further incubated for 48 h in the absence or
presence of human recombinant IL-1b (10 ng/ml). To determine the migratory
capacity of controls (n ¼ 60) and IL-1b-treated (n ¼ 60) placental explants, the area
of outgrowth was digitally photographed and analysed by using the imaging soft-
ware CellP as previously done [21,24].
2.6. Proliferation of ﬁrst trimester ﬂoating villi and primary EVT
To study the effects of IL-1b on proliferation of vCTB and cell column tropho-
blasts, 5-bromo-20-deoxy-uridine (BrdU) Labelling and Detection Kit III (Roche
Diagnostics, Vienna, Austria) was used as previously mentioned [22,24]. Brieﬂy,
dissected villi of three different ﬁrst trimester placentae were cultured in DMEM/
Ham’s F-12 medium, supplemented with 0.05 mg/ml gentamicin and 10 mMBrdU in
the absence (n ¼ 45) or presence (n ¼ 45) of human recombinant IL-1b (10 ng/ml)
and/or human recombinant IL-1Ra (40 ng/ml) for 24 h. Subsequently, 15 placental
villi of each condition were simultaneously embedded in parafﬁn and processed as
described in Section 2.3. Incorporated BrdU was detected by an anti-BrdU antibody
(monoclonal mouse, clone Bu20a, 2.6 mg/ml, Dako). The sections were counter-
stained with KRT and DAPI; secondary antibodies were used as described above.
Trophoblast proliferationwas quantiﬁed as the percentage of BrdU-labelled nuclei of
KRT-positive vCTB relative to the overall number of DAPI-positive nuclei of vCTB.
Between 500 and 600 nuclei of controls and stimulated conditions each were
counted. Analogously, the ratio of BrdU/DAPI-labelled cell column trophoblasts in
controls (300 nuclei) and IL-1b-stimulated villi (300 nuclei) was determined.
Primary EVT (1  105; n ¼ 3) were seeded in duplicates on ﬁbronectin-coated
chamber slides and incubated with 10 mM BrdU in the absence or presence of
human recombinant IL-1b (10 ng/ml). After 24 h, cells were ﬁxed in ethanol-ﬁxans
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above. Five non-overlapping pictures (100 fold magniﬁcation) of each condition
were taken and the ratio of BrdU/DAPI was evaluated.
2.7. Western blot analyses
Protein preparation and Western blot analyses were performed using standard
protocols as recently described [23]. Brieﬂy, supernatants were collected from
primary EVT cultivated for 48 h in DMEM/Ham’s F-12 medium with 10% FCS in the
absence or presence of human recombinant IL-1b (10 ng/ml) and/or human
recombinant IL-1Ra (40 ng/ml). Cell debris was removed after centrifugation
(1500 rpm, 5 min) and supernatants were concentrated using Ultrafree-MC ﬁlter
tubes (Millipore, Billerica, MA) according to the manufacturer’s instructions. EVT
were trypsinised for 5 min (0.25% Trypsin-EDTA, Gibco, Invitrogen) and counted
using a multi-channel electronic cell counter (CASY-I, Schärfe Systems, Reutlingen,
Germany). Supernatants were normalised to cell numbers, treated with protein
extraction buffer (ﬁnal concentration of 63 mM Tris.Cl, pH 6.8, 2% SDS, 0.1% b-
mercaptoethanol, 10% glycerol, 0.2 mg/ml bromophenol blue) and separated on 10%
SDS/PAA gels. PageRuler Plus (ThermoFisher Scientiﬁc, Waltham, MA) was used as
molecular size marker. Proteins were transferred onto PVDF membranes (Hybond-P,
Amersham, Pharmacia Biotech, Piscataway, NJ) and after blocking in 5% non-fat
dried milk in TBS-T, membranes were incubated with the following primary anti-
bodies, diluted in 5% BSA in TBS-T: uPA (monoclonal mouse, clone 204212, 1 mg/ml,
55 kDa-precursor, 35 kDa-active enzyme, R&D Systems Inc.), PAI-1 (monoclonal
mouse, 1 mg/ml, 47 kDa, Oncogene) and PAI-2 (monoclonal mouse, clone HD-PAI-2
22.1, 2 mg/ml, 48 kDa, American Diagnostica GmbH). After washing in TBS-T,
membranes were incubated with secondary anti-mouse Ig horseradish
peroxidase-linked antibodies (132 ng/ml, GE Healthcare, Little Chalfont, UK) and
developed for 5 min by using Amersham ECL Prime Western blotting reagent (GE
Healthcare). Protein quantiﬁcation was done by densitometrical scanning using
AlphaView software (Alpha Innotech, San Leandro, CA). For evaluation of cellular IL-
1R1 expression, protein extracts of EVT isolated after 48 h of cultivation on ﬁbro-
nectin were analysed as previously mentioned [21]. GAPDH (1 mg/ml, Ambion) was
used as loading control.
2.8. Statistics
Statistical analyses were performed using SPSS 18 (SPSS Inc., Chicago, IL) using
Student’s paired t-test. Gaussian distribution and equality of variances were
examined with KolmogoroveSmirnov test and Levene’s test, respectively. A p-value
<0.05 was considered statistically signiﬁcant.3. Results
3.1. Expression of IL-1R1 is associated with EVT differentiation
To gain insights into the expression pattern of IL-1R1 in
different trophoblast subpopulations, evaluation of previously
published gene chip data, immunoﬂuorescence of ﬁrst trimester
placental tissues and primary EVT, aswell asWestern blot analyses
were performed (Fig. 1). Recently, mRNA expression proﬁles of
trypsin-isolated ﬁrst trimester vCTB (n ¼ 5) and primary EVT,
isolated from differentiating villous explant cultures seeded on
Matrigel (n ¼ 6) were established [25]. Transcript levels of IL-1R1,
integrins (a5, a6) and HLA-G1 in vCTB and primary EVT cell pools
are depicted (Fig. 1A). Whereas IL-1bmRNA was absent from EVT
(data not shown), IL-1R1 transcripts were expressed at higher
levels in EVT similar to the differentiation-associated genes
integrin a5 and HLA-G1. Accordingly, immunoﬂuorescence of
primary EVT revealed that the number of IL-1R1-expressing cells
time-dependently increased upon cultivation on ﬁbronectin
concomitant with the differentiation-dependent elevation of the
EVT marker integrin a1 (Fig. 1B) as previously noticed [21]. Simi-
larly, immunoﬂuorescence of ﬁrst trimester placental tissue
sections (6th week) indicated elevated IL-1R1 protein in distal
regions of the cell column compared to vCTB and proximal cell
column trophoblasts (Fig. 1B). Accordingly, EVT which have
migrated into decidua basalis (11th week) also positively stained
for IL-1R1 (Fig. 1B). Western blot analyses revealed that total IL-
1R1 protein expression increased upon in vitro differentiation of
primary EVT cultivated on ﬁbronectin (Fig. 1C).3.2. IL-1b promotes motility of EVT
To analyse the effects of IL-1b on trophoblast migration, trans-
well assays with primary EVT were performed. Recombinant IL-1b
dose-dependently increased trophoblast motility which was
signiﬁcantly inhibited in the presence of IL-1Ra (Fig. 2A). However,
the antagonist did not inﬂuence basal migration of EVT suggesting
the absence of autocrine IL-1b signalling. Moreover, the cytokine
also stimulated migration of EVT in ﬁrst trimester villous explant
cultures on collagen I (Fig. 2B).
3.3. IL-1b does not affect proliferation of vCTB, cell column
trophoblasts and EVT
To test whether the effects of IL-1b on EVT invasion and
migration could be partly explained by increased cell growth,
proliferation of vCTB, cell column trophoblasts and EVT was ana-
lysed in ﬂoating villous explant cultures and primary cell isolates,
respectively, using BrdU-labelling (Fig. 3). Evaluation of the BrdU/
DAPI ratio in KRT-positive vCTB (Fig. 3A) and cell columns of villous
explant cultures (Fig. 3B), however, revealed that IL-1b did not alter
the proliferative capacity of these trophoblast subtypes. Similarly,
the cytokine did not affect proliferation of trypsin-isolated primary
EVT (Fig. 3C).
3.4. IL-1b induces uPA and PAI secretion in ﬁrst trimester villous
explant cultures and EVT
IL-1 has been well described as an inducer of the gelatinases
MMP-2 and MMP-9 in different trophoblast models [17,26e28].
However, the effects of the cytokine on other protease systems of
trophoblasts, such as the uPA/PAI system, are largely unknown.
Hence, IL-1b-dependent expression of uPA, PAI-1 and PAI-2 was
analysed in supernatants of the different trophoblast model
systems (Fig. 4). Western blot analyses of ﬁrst trimester villous
explant cultures seeded on collagen I revealed that IL-1b induced
secretion of uPA, PAI-1 and PAI-2, which was partly inhibited in the
presence of IL-1Ra (Fig. 4A). Similarly, treatment of different
primary EVT isolations with the cytokine provoked accumulation of
uPA, PAI-1 and PAI-2 in the supernatants (Fig. 4B).
4. Discussion
The cytokine IL-1 is awell-known regulator of acute and chronic
inﬂammatory processes [29,30]. The IL-1 protein family originally
consisted of two agonists, IL-1a and IL-1b, both recognizing IL-1R1
with high afﬁnity [30]. With the identiﬁcation of novel genes such
as IL-33, IL-36 or IL-38, the IL-1 family has expanded to eleven
different ligands and nine distinct receptors including co-receptors,
decoy receptors, inhibitory receptors and binding proteins [29].
Signalling through IL-1 involves binding of the ligand to the IL-1R1
chain, recruitment of IL-1R accessory protein (IL-1RAcP), interac-
tion of the cytoplasmic Toll-IL-1-like receptor domain with the
adaptor protein MyD88 and subsequent activation of the NFkB
pathway and kinases such as IL-1R1-associated kinase (IRAK) and
mitogen-activated protein kinase (MAPK) [31]. IL-1-dependent
signalling can be inhibited by IL-1Ra which blocks dimerisation of
IL-1R1 and IL-1RAcP upon binding to IL-1R1 [29].
Interestingly, accumulating evidence suggests that IL-1 also
plays a crucial role in implantation and reproductive success [32].
Indeed, pre-implantation embryos were shown to produce IL-1 at
maximal levels at the time of implantation and high concentrations
of the cytokine correlated with successful implantation rates after
IVF treatment [33e35]. Additionally, IL-1 was shown to regulate
human in vitro decidualisation and to provoke secretion of
Fig. 1. Expression of IL-1R1 in different human trophoblast subtypes. (A) Expression of IL-1R1 mRNA in 6 different primary EVT and 5 different vCTB cell pools measured by gene
chip analyses. Markers of EVT differentiation integrin a5 (ITGA5) and HLA-G1 were elevated in isolated EVT cell pools whereas the vCTB-associated gene integrin a6 (ITGA6) was
decreased. (B) IL-1R1 immunoﬂuorescence in ﬁrst trimester placental tissue (6th week), decidua basalis (11th week) and in ﬁrst trimester primary EVT (n ¼ 3) cultured for 24 and
48 h on ﬁbronectin. Pan-keratin (KRT) antibodies were used to depict trophoblasts in placental and decidual tissue sections. Four different ﬁrst trimester placentae, and three
different decidua basalis regions were analysed. Representative pictures at a 200 fold (tissue sections) and 400 fold (primary EVT) magniﬁcation are shown. Areas of villous stroma
(VS), cell column (CC), extravillous trophoblast (EVT) and villous cytotrophoblast (vCTB) are indicated. KRT-positive EVT expressing IL-1R1 in decidual tissue are marked by
*. Integrin a1 (ITGA1) was used to monitor matrix-dependent differentiation of primary EVT. (C) Western blot analyses of IL-1R1 in primary EVT cultivated for 24 and 48 h on
ﬁbronectin. GAPDH was used as a loading control. A representative example is shown. IL-1R1 signals were normalised to GAPDH protein expression using densitometrical scanning.
Bar graphs represent mean values  S.D. of three different experiments, * indicates p < 0.05.
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Fig. 2. IL-1b-dependent EVT motility. (A) Migration of ﬁrst trimester primary EVT through ﬁbronectin-coated transwells in the absence or presence of human recombinant IL-1b
and/or IL-1Ra. Invasion of CTK-7-positive trophoblasts was evaluated as described in Materials and methods. Bar graphs represent mean values  S.D. of three experiments
performed in duplicates. * indicates p < 0.05; ns, not signiﬁcant; (B) IL-1b induced migration of primary EVT in ﬁrst trimester villous explant cultures cultivated on collagen I.
Representative pictures are shown (200 fold magniﬁcation). Migration of trophoblasts was analysed as mentioned in Materials and methods. Bar graphs represent mean
values  S.D. of untreated (n ¼ 60) and IL-1b-stimulated (n ¼ 60) villous explants isolated from ﬁve different placentae. * indicates p < 0.05.
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[32]. Along those lines, published data suggest that IL-1 also
controls biological properties of placental trophoblasts. Besides
stimulation of human chorionic gonadotrophin (hCG) secretion
[36] and regulation of adhesion molecules [37], the cytokine has
beenwell described as an inducer of MMP-2, MMP-3 andMMP-9 in
JEG-3 cells, ﬁrst trimester trophoblasts and trophoblastic cell lines
[17,19,27,28].
IL-1 is likely released from decidual uNK cells, macrophages and
stromal cells suggesting paracrine effects on the invasive trophoblast
[38,39]. Moreover, stimulation of primary trophoblasts with
inﬂammatory LPS or hypoxia induced secretion of immunoreactive
IL-1 [17,40]. However, it remains controversial whether the cytokine
is also released from trophoblasts under physiological conditionsFig. 3. Effects of IL-1b on proliferation of vCTB, cell column trophoblasts and EVT. BrdU-labe
the BrdU/DAPI ratio were done as mentioned in Materials and methods. To measure prolife
placentae were utilised per condition. (A) Proliferation of vCTB in villous explant cultures in t
of 500e600 nuclei analysed per condition. ns, not signiﬁcant compared to untreated control
or presence of IL-1b. Bars indicate  S.D. ns, not signiﬁcant. (C) Proliferation of isolated prim
three different experiments/preparations performed in duplicates. ns, not signiﬁcant.and could therefore act in an autocrine manner. Previous studies
suggested IL-1 expression in vCTB of placental sections as well as
basal secretion from ﬁrst trimester trophoblasts prepared by Kli-
man’s method [17,41]. In contrast, others proposed that IL-1 protein
is absent in freshly isolated trophoblast preparations but rapidly
induced upon in vitro cultivation suggesting artiﬁcial activation [12].
Along those lines, IL-1a and IL-1bmRNAwere absent in three out of
six and six out of six different EVT cell pools, respectively, measured
by gene chip analyses (data not shown, accessible through GEO
proﬁles using the URL published in [25]). EVT analysed in this
comparative gene expression study have not been isolated by
enzymatic digestion, but by mechanical separation after outgrowth
of ﬁrst trimester villous explant cultures in serum-freemedium [25].
Hence, abnormal activation of IL-1 may only occur uponlling of ﬂoating villous explant cultures and isolated EVT, detection, and calculation of
ration of vCTB and cell column trophoblasts, 45 explants isolated from three different
he absence or presence of IL-1b and/or IL-1Ra. Bar graphs represent mean values  S.D.
s. (B) Proliferation of cell column trophoblasts in villous explant cultures in the absence
ary EVT in the absence or presence of IL-1b. Bar graphs represent mean values  S.D. of
Fig. 4. IL-1b-stimulated secretion of uPA and PAI proteins in ﬁrst trimester villous explant cultures and primary EVT. Western blot analyses of supernatants and quantiﬁcation were
done as described in Materials and methods. (A) Western blots showing IL-1b-dependent expression of uPA, PAI-1 and PAI-2 in ﬁrst trimester villous explant cultures in the absence
or presence of IL-1Ra. Bar graphs showmean values  S.D. of untreated and IL-1b- and/or IL-1Ra-stimulated explant cultures isolated from three different placentae, n ¼ 36 for each
condition; ns, not signiﬁcant, * indicates p < 0.05. (B) Western blot analyses of uPA, PAI-1 and PAI-2 in primary EVT after 48 h of IL-1b treatment. Two different EVT cell pools are
shown. Bar graphs represent mean values  S.D. of three different primary EVT cell isolations, * indicates p < 0.05.
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cultivation. In agreement with that, the gene chip analyses indicated
weak expression of IL-1a mRNA in ﬁve out of six vCTB cell pools
prepared by the enzymatic Kliman method. Furthermore, the
migration assays of primary EVT performed here do not support
autocrine production of IL-1, since IL-1Ra did not reduce their basal
motility.
Whereas IL-1 is either absent or very weakly expressed in
trophoblasts, expression of IL-1R1 is prominent in EVT. Here, we
show for the ﬁrst time that IL-1R1 protein expression increases in
distally located EVT of the cell column as well as in primary EVT
differentiating on extracellular matrix in vitro. Its expression is
maintained in EVT contacting stromal cells within the decidua
basalis suggesting paracrine responsiveness. In agreement with
the fact that IL-1R1 is rather weakly expressed in villous
trophoblasts and proximal cell columns, the cytokine did neither
affect proliferation of vCTB and cell column trophoblasts in
ﬂoating villous explant cultures nor cell growth of primary EVT.
On the other hand, upregulation of IL-1R1 during EVT differen-
tiation could indicate a role of IL-1 in trophoblast invasion.
Indeed, IL-1-dependent increase of trophoblast motility was
noticed in primary EVT and in villous explant cultures seeded on
collagen I. Besides the well-known IL-1-induced expression of
MMPs [19,27,28,42], the proteolytic activity of uPA could also be
involved since IL-1/IL-1R1-dependent accumulation of the
enzyme was observed in supernatants of primary EVT and villous
explant cultures. Elevated expression of uPA and PAI proteins in
the presence of IL-1 has also been described in many different
human cell types including endometrial stromal cells [43] and
was shown to be associated with increased invasion of various
cancer cell types [44e46]. On the other hand, uPA may promote
motility independently of its protease activity, since the non-
catalytic domain of uPA was shown to stimulate trophoblast
migration and signalling upon interaction with urokinase-type
plasminogen activator receptor [47].
With respect to trophoblast invasion, an indirect role of IL-1
through stimulation of IL-8 secretion from endometrial epithelial
cells has been described [18]. Although this mechanism might
contribute to IL-1-dependent implantation and early invasion, data
obtained from the two different primary trophoblast cell models
shown here conﬁrm a direct, positive role of IL-1 in trophoblastmotility as previously suggested [17]. In contrast, trophoblastic
SGHPL-4 cells did not show increased invasion upon IL-1 treatment
despite elevated MMP expression [19]. Hence, caution has to be
taken when studies with trophoblastic cell lines are interpreted in
the context of physiological trophoblast invasion. This is also
reﬂected by the fact that the cytokine exerts differential effects on
cell growth of primary and tumorigenic trophoblasts. Whereas IL-
1-dependent decrease of JAR cell proliferation [48] and IL-1b-
induced expansion of AC-1M88 spheroids [49] were noticed,
proliferation was unaffected in our different primary trophoblast
cell models.
Despite the fact that IL-1 increased motility of primary
trophoblasts in vitro, the importance of IL-1 as a physiological
regulator of trophoblast invasion remains uncertain. Whereas low
levels of IL-1 may control implantation and early trophoblast
invasion processes, continuous expression of the pro-inﬂammatory
cytokine may have detrimental effects on pregnancy. Indeed, some
authors believe that pregnancy is associatedwith a decrease of pro-
inﬂammatory and T helper (Th1) cytokines such as IL-1 and TNFa
and induction of anti-inﬂammatory Th2 cytokines which might
reduce aberrant inﬂammation, damage and allograft rejection of
the fetus [50]. However, considering different immunological
phases of pregnancy and complex interactions between uterine cell
types, the concept of Th1/Th2 shift is probably too simplistic and
remains a matter of discussion [51e54]. Hence, elevated concen-
trations of active IL-1 may not necessarily be harmful for the
placenta and progression of gestation. Bearing this in mind,
a physiological role of IL-1 in trophoblast invasion at later times of
pregnancy cannot be excluded. On the other hand, the bioactivity of
IL-1 secreted from decidual stromal cells in vitro and in vivo is
either absent or very low [39]. Also, uNK cells and macrophages
may secrete the active cytokine mainly under inﬂammatory
conditions. Indeed, exceeding levels of IL-1 and other Th1 cytokines
were shown to be associated with various pregnancy diseases such
as recurrent spontaneous abortion, preterm rupture of membranes,
preterm labour and preeclampsia [15].
Although the inﬂammatory response provoked by IL-1 is
considered as an adverse effect of the cytokine, one could also
argue that it is important for immunosurveillance of gestation [55].
Upon infection bioactive IL-1 could be quickly released from its
precursor, bind to EVTs and other uterine cell types via IL-1R1 and
N. Prutsch et al. / Placenta 33 (2012) 696e703702induce abnormal levels of uPA andMMPs. The enhanced proteolytic
activity might then cause abnormal matrix degradation within the
decidua impairing physiological trophoblast migration and
inducing placental abruption. Such a mechanismwould protect the
mother from spreading of an infection, even at the expense of fetal
survival. This evolutionary strategy might be still of importance in
countries where women have limited access to anti-infective
therapies.
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